{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:36:30Z","timestamp":1782754590195,"version":"3.54.5"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.amjcard.2019.10.024","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T19:01:51Z","timestamp":1573758111000},"page":"S3-S11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"S1","title":["Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship"],"prefix":"10.1016","volume":"124","author":[{"given":"Michael J.","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adena","family":"Zadourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam R.","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjcard.2019.10.024_bb0005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00125-018-4801-1","article-title":"Cardiovascular outcome trials of glucose-lowering medications: an update","volume":"62","author":"Home","year":"2019","journal-title":"Diabetologia"},{"issue":"22","key":"10.1016\/j.amjcard.2019.10.024_bb0010","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.amjcard.2019.10.024_bb0015","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amjcard.2019.10.024_bb0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjcard.2019.10.024_bb0025","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.amjcard.2019.10.024_bb0030","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.amjcard.2019.10.024_bb0035","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","article-title":"Impact of diabetes on cardiac structure and function: the strong heart study","volume":"101","author":"Devereux","year":"2000","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.amjcard.2019.10.024_bb0040","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0735-1097(01)01230-X","article-title":"The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the strong heart study","volume":"37","author":"Liu","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.amjcard.2019.10.024_bb0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1096-9136(199604)13:4<321::AID-DIA3>3.0.CO;2-7","article-title":"Diastolic dysfunction in patients with non-insulin-dependent diabetes mellitus of short duration","volume":"13","author":"Di Bonito","year":"1996","journal-title":"Diabet Med"},{"issue":"7","key":"10.1016\/j.amjcard.2019.10.024_bb0050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.amjmed.2006.05.024","article-title":"Diabetes in heart failure: prevalence and impact on outcome in the population","volume":"119","author":"From","year":"2006","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.amjcard.2019.10.024_bb0055","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jacc.2003.11.040","article-title":"Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York heart failure registry","volume":"43","author":"Klapholz","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.amjcard.2019.10.024_bb0060","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.amjcard.2019.10.024_bb0065","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amjcard.2019.10.024_bb0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"10.1016\/j.amjcard.2019.10.024_bb0075","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2337\/diacare.26.10.2791","article-title":"Diabetes and idiopathic cardiomyopathy: a nationwide case-control study","volume":"26","author":"Bertoni","year":"2003","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.amjcard.2019.10.024_bb0080","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/diacare.24.9.1614","article-title":"Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors","volume":"24","author":"Nichols","year":"2001","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.amjcard.2019.10.024_bb0085","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1378\/chest.115.3.867","article-title":"Incidence of heart failure in 2,737 older persons with and without diabetes mellitus","volume":"115","author":"Aronow","year":"1999","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.amjcard.2019.10.024_bb0090","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/diacare.28.3.612","article-title":"The association between glucose abnormalities and heart failure in the population-based Reykjavik study","volume":"28","author":"Thrainsdottir","year":"2005","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.amjcard.2019.10.024_bb0095","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ejhf.600","article-title":"Reframing the association and significance of co-morbidities in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.amjcard.2019.10.024_bb0100","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1007\/s00125-012-2579-0","article-title":"High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes","volume":"55","author":"Boonman-de Winter","year":"2012","journal-title":"Diabetologia"},{"issue":"23","key":"10.1016\/j.amjcard.2019.10.024_bb0105","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","article-title":"Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.amjcard.2019.10.024_bb0110","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.114.010815","article-title":"Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage","volume":"130","author":"Selvin","year":"2014","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.amjcard.2019.10.024_bb0115","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.amjcard.2019.10.024_bb0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvr212","article-title":"Lipotoxicity in type 2 diabetic cardiomyopathy","volume":"92","author":"van de Weijer","year":"2011","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.amjcard.2019.10.024_bb0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.amjcard.2019.10.024_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart failure in type 2 diabetes mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.amjcard.2019.10.024_bb0135","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","article-title":"The failing heart relies on ketone bodies as a fuel","volume":"133","author":"Aubert","year":"2016","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.amjcard.2019.10.024_bb0140","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.10.024_bb0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.metabol.2017.08.005","article-title":"The diabetic heart utilizes ketone bodies as an energy source","volume":"77","author":"Mizuno","year":"2017","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.amjcard.2019.10.024_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jacc.2016.03.597","article-title":"Ectopic and visceral fat deposition in lean and obese patients with type 2 diabetes","volume":"68","author":"Levelt","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.amjcard.2019.10.024_bb0155","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/CIRCULATIONAHA.117.030418","article-title":"Activation and inhibition of sodium-hydrogen exchanger is a mechanism that links the pathophysiology and treatment of diabetes mellitus with that of heart failure","volume":"136","author":"Packer","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.amjcard.2019.10.024_bb0160","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","article-title":"Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na(+)\/H(+) exchanger, lowering of cytosolic Na(+) and vasodilation","volume":"61","author":"Uthman","year":"2018","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.amjcard.2019.10.024_bb0165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002183","article-title":"Intracellular Na+ concentration ([Na+]i) is elevated in diabetic hearts due to enhanced Na+-glucose cotransport","volume":"4","author":"Lambert","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.amjcard.2019.10.024_bb0170","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.amjcard.2019.10.024_bb0175","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"10","key":"10.1016\/j.amjcard.2019.10.024_bb0180","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"10.1016\/j.amjcard.2019.10.024_bb0185","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/archinternmed.2009.40","article-title":"Epidemiology of incident heart failure in a contemporary elderly cohort: the Health, Aging, and Body Composition study","volume":"169","author":"Kalogeropoulos","year":"2009","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.amjcard.2019.10.024_bb0190","first-page":"e2","article-title":"Heart disease and stroke statistics--2012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.amjcard.2019.10.024_bb0195","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa0807265","article-title":"Racial differences in incident heart failure among young adults","volume":"360","author":"Bibbins-Domingo","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjcard.2019.10.024_bb0200","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","article-title":"A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010","volume":"175","author":"Gerber","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.amjcard.2019.10.024_bb0205","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.amjcard.2013.10.032","article-title":"Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities study)","volume":"113","author":"Chang","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.10.024_bb0210","author":"Centers for Disease Control and Prevention, National Center for Health Statistics"},{"key":"10.1016\/j.amjcard.2019.10.024_bb0215","author":"World Health Organization"},{"key":"10.1016\/j.amjcard.2019.10.024_bb0220","series-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2017"},{"key":"10.1016\/j.amjcard.2019.10.024_bb0225","series-title":"National Diabetes Statistics Report, 2017: Estimates of Diabetes and its Burden in the United States","author":"Centers for Disease Control and Prevention","year":"2017"},{"issue":"8","key":"10.1016\/j.amjcard.2019.10.024_bb0230","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/M13-2411","article-title":"Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010","volume":"160","author":"Selvin","year":"2014","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.amjcard.2019.10.024_bb0235","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1573403X12666160606120254","article-title":"Type 2 diabetes and heart failure: challenges and solutions","volume":"12","author":"Thomas","year":"2016","journal-title":"Curr Cardiol Rev"},{"issue":"1","key":"10.1016\/j.amjcard.2019.10.024_bb0240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0002-8703(99)70251-6","article-title":"Insights into the contemporary epidemiology and outpatient management of congestive heart failure","volume":"138","author":"McAlister","year":"1999","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.amjcard.2019.10.024_bb0245","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11892-018-1116-z","article-title":"Revisiting the diabetes-heart failure connection","volume":"18","author":"Wallner","year":"2018","journal-title":"Curr Diab Rep"},{"issue":"8","key":"10.1016\/j.amjcard.2019.10.024_bb0250","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","article-title":"The incidence of congestive heart failure in type 2 diabetes: an update","volume":"27","author":"Nichols","year":"2004","journal-title":"Diabetes Care"},{"issue":"1S","key":"10.1016\/j.amjcard.2019.10.024_bb0255","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.amjcard.2017.05.014","article-title":"Diabetes mellitus and heart failure","volume":"120","author":"Lehrke","year":"2017","journal-title":"Am J Cardiol"},{"issue":"16","key":"10.1016\/j.amjcard.2019.10.024_bb0260","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/euhj.1999.2043","article-title":"Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure","volume":"21","author":"Suskin","year":"2000","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.amjcard.2019.10.024_bb0265","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.amjcard.2019.10.024_bb0270","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jchf.2014.08.004","article-title":"Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure","volume":"3","author":"Dei Cas","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10.1016\/j.amjcard.2019.10.024_bb0275","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/eurheartj\/ehn156","article-title":"Diabetes, left ventricular systolic dysfunction, and chronic heart failure","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.amjcard.2019.10.024_bb0280","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0735-1097(00)00582-9","article-title":"Predictors of congestive heart failure in the elderly: the cardiovascular health study","volume":"35","author":"Gottdiener","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.amjcard.2019.10.024_bb0285","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study","volume":"161","author":"He","year":"2001","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.amjcard.2019.10.024_bb0290","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diacare.27.3.699","article-title":"Heart failure prevalence, incidence, and mortality in the elderly with diabetes","volume":"27","author":"Bertoni","year":"2004","journal-title":"Diabetes Care"},{"issue":"22","key":"10.1016\/j.amjcard.2019.10.024_bb0295","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","article-title":"Glycemic control and heart failure among adult patients with diabetes","volume":"103","author":"Iribarren","year":"2001","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.amjcard.2019.10.024_bb0300","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.amjcard.2012.02.022","article-title":"Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus","volume":"109","author":"Tomova","year":"2012","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.amjcard.2019.10.024_bb0305","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jacc.2003.10.033","article-title":"Impact of race on health care utilization and outcomes in veterans with congestive heart failure","volume":"43","author":"Deswal","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.amjcard.2019.10.024_bb0310","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2005.02.093","article-title":"Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure","volume":"46","author":"Doehner","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.amjcard.2019.10.024_bb0315","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/hrt.2005.080895","article-title":"Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure","volume":"92","author":"Newton","year":"2006","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.amjcard.2019.10.024_bb0320","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/archinte.159.5.505","article-title":"Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population","volume":"159","author":"Croft","year":"1999","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.amjcard.2019.10.024_bb0325","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.CIR.102.10.1126","article-title":"Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995","volume":"102","author":"MacIntyre","year":"2000","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.amjcard.2019.10.024_bb0330","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0735-1097(03)00856-8","article-title":"The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial","volume":"42","author":"Domanski","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.amjcard.2019.10.024_bb0335","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0735-1097(01)01408-5","article-title":"Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction","volume":"38","author":"Dries","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.amjcard.2019.10.024_bb0340","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.amjmed.2003.09.035","article-title":"A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction","volume":"116","author":"Brophy","year":"2004","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.amjcard.2019.10.024_bb0345","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jacc.2003.11.024","article-title":"Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure","volume":"43","author":"Gustafsson","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjcard.2019.10.024_bb0350","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/eurheartj\/ehi555","article-title":"Predictors of mortality andmorbidity in patients with chronic heart failure","volume":"27","author":"Pocock","year":"2006","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.amjcard.2019.10.024_bb0355","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.amjcard.2010.02.018","volume":"106","author":"de Boer","year":"2010","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.amjcard.2019.10.024_bb0360","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002560","article-title":"Risk related to pre-diabetes mellitus and diabetes mellitus in heart failure With reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial","volume":"9","author":"Kristensen","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.amjcard.2019.10.024_bb0365","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2337\/dc17-0697","article-title":"Prognostic impact of diabetes on long-term survival outcomes in patients with heart failure: a meta-analysis","volume":"40","author":"Dauriz","year":"2017","journal-title":"Diabetes Care"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919311737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919311737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:05:16Z","timestamp":1762077916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914919311737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":73,"alternative-id":["S0002914919311737"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.10.024","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}